---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292659812.md"
description: "During Tuesday's intraday session, several healthcare stocks experienced significant volatility. NextCure (NXTC) surged 201.4% to $6.57, while Shuttle Pharmaceuticals (SHPH) rose 39.86%. Other gainers included Galectin Therapeutics, BioXcel Therapeutics, Actuate Therapeutics, and Cibus. Conversely, Matinas BioPharma (MTNB) fell 32.1%, with Z Squared, Spero Therapeutics, Regentis Biomaterials, Carlsmed, and Valion Bio also posting declines."
datetime: "2026-07-14T17:05:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292659812.md)
  - [en](https://longbridge.com/en/news/292659812.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292659812.md)
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **NextCure** (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) shares rose 39.86% to $4.14. The company's market cap stands at $1.7 million.
-   **Galectin Therapeutics** (NASDAQ:GALT) stock moved upwards by 19.13% to $5.48. The company's market cap stands at $302.9 million.
-   **BioXcel Therapeutics** (NASDAQ:BTAI) shares rose 17.89% to $1.04. The market value of their outstanding shares is at $27.2 million.
-   **Actuate Therapeutics** (NASDAQ:ACTU) shares increased by 17.66% to $1.76. The market value of their outstanding shares is at $35.8 million.
-   **Cibus** (NASDAQ:CBUS) stock moved upwards by 17.37% to $2.5. The company's market cap stands at $162.5 million.

### Losers

-   **Matinas BioPharma Hldgs** (AMEX:MTNB) shares fell 32.1% to $0.33 during Tuesday's regular session. The market value of their outstanding shares is at $3.0 million.
-   **Z Squared** (NASDAQ:ZSQR) shares decreased by 21.95% to $5.62. The company's market cap stands at $379.6 million.
-   **Spero Therapeutics** (NASDAQ:SPRO) shares fell 19.72% to $1.75. The company's market cap stands at $126.2 million.
-   **Regentis Biomaterials** (AMEX:RGNT) stock declined by 16.72% to $2.89. The market value of their outstanding shares is at $24.3 million.
-   **Carlsmed** (NASDAQ:CARL) shares declined by 14.95% to $10.3. The company's market cap stands at $329.2 million.
-   **Valion Bio** (NASDAQ:VBIO) stock declined by 14.49% to $0.43. The company's market cap stands at $1.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GALT.US](https://longbridge.com/en/quote/GALT.US.md)
- [CARL.US](https://longbridge.com/en/quote/CARL.US.md)
- [SPRO.US](https://longbridge.com/en/quote/SPRO.US.md)
- [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md)
- [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [RGNT.US](https://longbridge.com/en/quote/RGNT.US.md)
- [ACTU.US](https://longbridge.com/en/quote/ACTU.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [ZSQR.US](https://longbridge.com/en/quote/ZSQR.US.md)
- [CBUS.US](https://longbridge.com/en/quote/CBUS.US.md)

## Related News & Research

- [Craig-Hallum Remains a Buy on Actuate Therapeutics, Inc. (ACTU)](https://longbridge.com/en/news/286113939.md)
- [Galectin Therapeutics posts corporate presentation highlighting belapectin program for MASH cirrhosis, portal hypertension](https://longbridge.com/en/news/292638312.md)
- [Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties](https://longbridge.com/en/news/293798083.md)
- [Z Squared Ends Equity Facilities, Refines Capital Strategy](https://longbridge.com/en/news/293526834.md)
- [BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity](https://longbridge.com/en/news/291789314.md)